CDK8-IN-11 is a selective and potent CDK8 inhibitor that shows antiproliferative activity in colon cancer cell lines, inhibiting WNT/beta-catenin activation and TCF family transcriptional activity, inducing G1-phase arrest in HCT-116 cells, useful for colon cancer research.
Molecular Weight:
388.34
Purity:
99.74%
CAS Number:
[2839338-28-0]
Formula:
C19H15F3N4O2
Target:
CDK|||Wnt/beta-catenin
T61742
T61742
* VAT and and shipping costs not included. Errors and price changes excepted